A study by Baine et al. was the first study that used surrogate immunohistochemical (IHC) analysis for novel SCLC subtypes, in which they confirmed the previous findings in patient samples, while also documenting a significant level of co-expression between ASCL1 and NEUROD1. This evidence concerns the gene ASCL1 and small cell lung carcinoma.